Utah Medical Products (UTMD) Current Deferred Tax Assets (2010 - 2016)

Utah Medical Products' Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $393000.0 for Q4 2016.

• In Q4 2016, Current Deferred Tax Assets rose 8.26% year-over-year to $393000.0; the TTM figure through Dec 2016 stood at $393000.0 (up 8.26% YoY), while the FY2016 annual figure was $393000.0, up 8.26% from the prior year.
• Current Deferred Tax Assets was $393000.0 for Q4 2016 at Utah Medical Products, up from $363000.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $451000.0 in Q4 2012 to a low of $303000.0 in Q4 2014.
• Historically, Current Deferred Tax Assets has averaged $367600.0 across 5 years, with a median of $363000.0 in 2015.
• The sharpest annual moves came in 2012 and 2013: Current Deferred Tax Assets surged 35.44% in 2012, then declined 27.27% in 2013.
• A 5-year view of Current Deferred Tax Assets shows it stood at $451000.0 in 2012, then slipped by 27.27% to $328000.0 in 2013, then declined by 7.62% to $303000.0 in 2014, then climbed by 19.8% to $363000.0 in 2015, then rose by 8.26% to $393000.0 in 2016.
• The last three Current Deferred Tax Assets figures came in at $393000.0 (Q4 2016), $363000.0 (Q4 2015), and $303000.0 (Q4 2014), per Business Quant data.